Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 475 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 01/01/13
End: 08/07/20
Due: 08/07/21
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: -
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 10/31/33
Due: 10/31/34
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 11/22/02
End: 03/10/14
Due: 03/10/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
Phase: N/A
Priority: Normal
Start: 09/04/15
End: 08/11/17
Due: 08/11/18
Phase: N/A
Priority: Normal
Start: 06/05/06
End: 03/13/17
Due: 03/13/18
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: -
End: 11/30/97
Due: 11/30/98
Phase: N/A
Priority: Normal
Start: 01/03/24
End: 12/20/25
Due: 12/20/26
Phase: N/A
Priority: Normal
Start: 04/20/11
End: 10/18/23
Due: 10/18/24
Phase: N/A
Priority: Normal
Start: 03/03/09
End: 03/10/10
Due: 03/10/11
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 11/24/18
Due: 11/24/19
Phase: N/A
Priority: Normal
Start: 07/02/25
End: 12/01/44
Due: 12/01/45
Phase: N/A
Priority: Normal
Start: 04/17/24
End: 12/31/32
Due: 12/31/33
Phase: N/A
Priority: Normal
Start: 07/02/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 12/04/20
End: 07/25/24
Due: 07/25/25
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -